The primary difference between the Wegovy pill and the injection is how you take them and how often. The Wegovy pill is a daily tablet you swallow, while the Wegovy injection is a once-weekly shot you ...

Wegovy pill, the first FDA‑approved oral GLP‑1 for weight loss, is now available via WeightWatchers Med+ from $149 per month ...

On December 22, 2025, the U.S. Food and Drug Administration (FDA) approved an oral pill form of Wegovy — a glucagon-like peptide-1 (GLP-1) receptor agonist medication for weight loss. Until now, ...

Your doctor will help you decide which form, pill or injection, of Wegovy is best for you. It may depend on your medical history, which dosing schedule fits your lifestyle better, and how comfortable ...

“The GLP-1 landscape is expected to broaden significantly,” said Dr. Christopher McGowan, a gastroenterologist who runs a weight loss clinic in Cary, North Carolina. “For the first time, medical ...

A recent FDA approval means consumers now have two GLP-1 weight loss pills to choose from as an alternative to the ...

The arrival of the Wegovy pill (semaglutide), the first oral GLP-1 drug approved to treat obesity, means freedom of choice: Adults who are looking to lose weight and have at least one weight-related ...

Wegovy HD will be available in April across all distribution channels, including retail pharmacies and select telehealth providers. The Food and Drug Administration (FDA) has approved Wegovy ® HD ...

On January 5, 2026, Novo Nordisk announced it had launched an oral tablet version of its injectable GLP-1 weight-loss medication, Wegovy (semaglutide). The GLP-1 pill is still prescription-only, but ...

Americans seeking to lose weight now have a new option – taking Wegovy as a daily pill, rather than a weekly injection. Patients with a prescription could obtain the starter 1.5 mg dose of the tablet ...

Novo Nordisk has presented fresh data from the OASIS 4 trial at the European Congress on Obesity 2026, showing strong ...